- o-DON
- 3,4-Dimethoxy-2-nitroamphetamine
- 2-NO2-4,5-DMA
Scorza, MC; Carrau, C; Silveira, R; Zapata-Torres, G; Cassels, BK; Reyes-Parada, M. Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives Biochem. Pharmacol., 15 Dec 1997, 54 (12), 1361–1369. 697 kB. https://doi.org/10.1016/S0006-2952(97)00405-X #26 2NO2-4,5-DMA
Jara, AN; Torres, MA; Cassels, BK; Rezende, MC. Some fluoro and nitro analogues of hallucinogenic amphetamines Synth. Commun., 1 Jan 1994, 24 (3), 417–426. 440 kB. https://doi.org/10.1080/00397919408011201 #4 Rhodium. NMR,IR
Nuñez-Vergara, LJ; Matus, C; Alvarez-Lueje, AF; Cassels, BK; Squella, JA. Nitro radical anion formation from nitro-substituted amphetamine derivatives Electroanalysis, 1 May 1994, 6 (5–6), 509–513. 477 kB. https://doi.org/10.1002/elan.1140060525 #NDMA other
Reyes-Parada, M; Iturriaga-Vasquez, P; Cassels, BK. Amphetamine derivatives as monoamine oxidase inhibitors Front. Pharmacol., 23 Jan 2020, 10 1590. 1.9 MB. https://doi.org/10.3389/fphar.2019.01590 #2-NO2-DMA
Vallejos, G; Rezende, MC; Cassels, BK. Charge-transfer interactions in the inhibition of MAO-A by phenylisopropylamines – a QSAR study J. Comput. Aided Mol. Des., 1 Feb 2002, 16 (2), 95–103. 105 kB. https://doi.org/10.1023/A:1016344030772 #26